Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Accumulated Expenses (2016 - 2025)

LivaNova's Accumulated Expenses history spans 11 years, with the latest figure at $92.9 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 21.58% year-over-year to $92.9 million; the TTM value through Dec 2025 reached $92.9 million, down 21.58%, while the annual FY2025 figure was $92.9 million, 21.58% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $92.9 million at LivaNova, up from $80.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $118.5 million in Q4 2024 and bottomed at $50.3 million in Q2 2022.
  • The 5-year median for Accumulated Expenses is $81.2 million (2023), against an average of $81.8 million.
  • The largest annual shift saw Accumulated Expenses soared 167.84% in 2021 before it crashed 49.84% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $79.3 million in 2021, then fell by 8.93% to $72.2 million in 2022, then soared by 31.09% to $94.6 million in 2023, then grew by 25.21% to $118.5 million in 2024, then decreased by 21.58% to $92.9 million in 2025.
  • Per Business Quant, the three most recent readings for LIVN's Accumulated Expenses are $92.9 million (Q4 2025), $80.3 million (Q3 2025), and $67.6 million (Q2 2025).